Related Experiment Video
Updated: Jul 11, 2026

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
Revascularization in high risk patients: diabetes mellitus
1Interventional Cardiology Unit, Department of Cardiology, Sant Pau University Hospital, Barcelona, Spain.
Insights
Coronary artery disease poses significant risks for diabetic patients. While coronary artery bypass grafting (CABG) is generally preferred over percutaneous coronary intervention (PCI), newer drug-eluting stents are being investigated for improved outcomes in diabetics.
Area of Science:
- Cardiology
- Diabetology
- Vascular Surgery
Background:
- Diabetes mellitus significantly increases morbidity and mortality due to coronary artery disease.
- Diabetic atherosclerosis exhibits unique characteristics, posing challenges for revascularization strategies.
- Both percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) show inferior outcomes in diabetic patients compared to non-diabetics.
Purpose of the Study:
- To provide an updated review of current evidence on coronary revascularization in diabetic patients.
- To address the evolution of PCI, particularly drug-eluting stents, in this population.
- To analyze comparative efficacy and safety of CABG versus PCI, including recent trial data.
Main Methods:
- Review of current literature and clinical trials comparing CABG and PCI in diabetic patients.
- Evaluation of the efficacy and safety of drug-eluting stents in diabetic individuals.
- Analysis of potential complications associated with each revascularization modality.
- Focus on specific subgroups, including acute coronary syndromes and systemic diabetic complications.
Main Results:
- Coronary artery bypass graft (CABG) has historically demonstrated superior efficacy compared to percutaneous coronary intervention (PCI) in diabetic patients.
- Current guidelines recommend CABG for multivessel disease in diabetics.
- The effectiveness and safety of newer PCI technologies, such as drug-eluting stents, are under ongoing investigation.
Conclusions:
- Coronary revascularization in diabetic patients remains complex, with CABG often favored.
- Further research is needed to fully elucidate the role of advanced PCI techniques, like drug-eluting stents, in managing coronary artery disease in diabetics.
- Personalized treatment strategies considering patient-specific factors and complications are crucial.
Abstract:
Coronary artery disease is the main cause of morbidity and mortality in patients affected by diabetes mellitus. Pathophysiology of atherosclerosis in diabetics exhibit specific characteristics that confer them a high risk. In this regard, revascularization in diabetic patients remains a challenge. Both techniques [percutaneous coronary interventions (PCI) and coronary artery bypass graft (CABG)] demonstrate poorer outcomes in diabetics as compared to non diabetic patients. When one revascularization modality has been compared against the other, CABG has consistently demonstrated to be more efficacious than PCI. Thus, current guidelines recommend CABG for the treatment of multivessel disease in diabetics. However, the efficacy of recent developments in the PCI field (i.e. drug-eluting stent) is currently under investigation. The aim of this review is to update current evidence in the field of coronary revascularization in diabetics. Evolution of PCI over time will be specifically addressed as well as current evidence of drug-eluting stents in terms of efficacy and safety in diabetics. Besides, main CABG vs PCI trials will be reviewed. Additionally, we will focus on potential complications to be faced in either revascularization modality. Finally, revascularization in specific subgroup of diabetic patients such as those presenting with acute coronary syndromes or those with diabetes-related systemic complications will also be addressed.
Related Concept Videos
Diabetic Retinopathy
Peripheral Artery Disease V: Postoperative Nursing Management
Complications of Diabetes Mellitus
Diabetic Foot Ulcer
Peripheral Artery Disease III: Interprofessional Care
